Eli Lilly stock dips after hours as Jardiance, Mounjaro price-cut headlines land into 2026
Eli Lilly shares fell 0.5% to $1,074.68 in after-hours trading Wednesday after reports of major drug price cuts in the U.S. and China for diabetes and weight-loss medicines. Reuters said Jardiance’s U.S. list price will drop over 40% in 2026, while Mounjaro’s price in China will fall from 2,180 yuan to 445 yuan starting Jan. 1.